Our collaborative experts. Your trusted CRO partner.
At Aquila, our vision is to be a global leader in innovative contract research. Through cutting-edge research, we aim to help our clients secure the best route to clinic to develop new medicines that benefit human health.
Encompassed within our vision is our desire to develop high-impact, clinically-relevant assays to meet our clients’ requirements.
For client-led projects, we will discuss your project needs, validating new methods and assays to deliver on our agreed objectives. Flexibility and creativity are key to success. We are committed to close collaboration with you, and using open innovation to build new, clinically-relevant models to the highest quality standards.
We are currently building on our immuno-oncology capabilities, particularly ovarian tumour ascites and fresh human tumour samples (Human Tumour Ex-vivo Systems). With these assays, we aim to generate high-value mechanistic ‘human’ data on novel immunomodulators that can be taken forward into in vivo models or to clinic.
Please get in touch to develop a project or learn more about our current research.